J Y Li

697 total citations
46 papers, 284 citations indexed

About

J Y Li is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, J Y Li has authored 46 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 18 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in J Y Li's work include Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (13 papers) and Chronic Lymphocytic Leukemia Research (8 papers). J Y Li is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), Viral-associated cancers and disorders (13 papers) and Chronic Lymphocytic Leukemia Research (8 papers). J Y Li collaborates with scholars based in China, United States and Macao. J Y Li's co-authors include Baohua Yu, Xiaoyan Zhou, Pingyong Yi, Yajun Li, Di Shi, Yifan Su, Meizuo Zhong, Ping Wei, Hui Zhou and Xiaoqiu Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

J Y Li

38 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Y Li China 11 156 129 75 70 34 46 284
Monalisa Ghosh United States 9 170 1.1× 46 0.4× 87 1.2× 63 0.9× 13 0.4× 45 308
Irene Ekwede United States 9 273 1.8× 81 0.6× 139 1.9× 67 1.0× 26 0.8× 25 360
Felix Weihsengruber Austria 8 122 0.8× 98 0.8× 39 0.5× 41 0.6× 11 0.3× 15 253
Caroline Hammer Switzerland 10 170 1.1× 60 0.5× 122 1.6× 44 0.6× 61 1.8× 15 350
Nathan Denlinger United States 10 213 1.4× 55 0.4× 76 1.0× 111 1.6× 11 0.3× 31 336
Kai Hu China 13 130 0.8× 74 0.6× 220 2.9× 39 0.6× 106 3.1× 59 456
Ron D. Jachimowicz Germany 10 161 1.0× 97 0.8× 104 1.4× 130 1.9× 32 0.9× 17 319
Farah Abdulla United States 10 204 1.3× 146 1.1× 73 1.0× 232 3.3× 9 0.3× 47 487
Jean-David Fumet France 10 332 2.1× 48 0.4× 90 1.2× 198 2.8× 57 1.7× 29 460
Carmelo Laface Italy 11 121 0.8× 30 0.2× 92 1.2× 47 0.7× 29 0.9× 34 291

Countries citing papers authored by J Y Li

Since Specialization
Citations

This map shows the geographic impact of J Y Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Y Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Y Li more than expected).

Fields of papers citing papers by J Y Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Y Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Y Li. The network helps show where J Y Li may publish in the future.

Co-authorship network of co-authors of J Y Li

This figure shows the co-authorship network connecting the top 25 collaborators of J Y Li. A scholar is included among the top collaborators of J Y Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Y Li. J Y Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Xing, et al.. (2025). GNPAT / USP30 Stabilizes DRP1 Protein to Promote Mitochondrial Fission and Functional Damage in COPD Progression. The Kaohsiung Journal of Medical Sciences. 41(12). e70080–e70080. 1 indexed citations
2.
Zhang, Shuo, et al.. (2025). Low-profile energy-effective cooling devices using the radial acoustic black hole. International Journal of Mechanical Sciences. 308. 110972–110972.
5.
Li, J Y, et al.. (2024). Prognostic analysis of nimotuzumab combined with concurrent chemoradiotherapy in locally advanced cervical cancer: A multicenter real-world study.. Journal of Clinical Oncology. 42(16_suppl). 5532–5532. 1 indexed citations
6.
Liu, Hui, Hu Chen, Zhenjie Li, et al.. (2024). Rhein‐based Pickering emulsion for hepatocellular carcinoma: Shaping the metabolic signaling and immunoactivation in transarterial chemoembolization. SHILAP Revista de lepidopterología. 5(4). 24 indexed citations
7.
Li, J Y, Hongling Peng, Xiaoyan Zhou, & Jingjing Wang. (2024). Plasmablastic lymphoma: current knowledge and future directions. Frontiers in Immunology. 15. 1354604–1354604. 4 indexed citations
8.
Xue, Tian, Jiaxin Lin, J Y Li, et al.. (2024). Yin Yang 1 expression predicts a favourable survival in diffuse large B-cell lymphoma. Heliyon. 10(2). e24376–e24376. 1 indexed citations
9.
Yin, Hang, Wei Hua, Yinghui Li, et al.. (2024). [Efficacy and safety analysis of the OR-CHOP regimen for the treatment of MCD subtype diffuse large B cell lymphoma in the real-world setting].. PubMed. 45(9). 827–831. 1 indexed citations
10.
Li, Hongwen, Wenting Song, J Y Li, et al.. (2023). CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma. BMC Medicine. 21(1). 330–330. 14 indexed citations
11.
Li, J Y, et al.. (2023). The biology and treatment of Epstein-Barr virus-positive diffuse large B cell lymphoma, NOS. Heliyon. 10(1). e23921–e23921. 8 indexed citations
13.
14.
Su, Yifan, Qianlan Yao, Yuyin Xu, et al.. (2021). Characteristics of Germline Non-BRCA Mutation Status of High-Risk Breast Cancer Patients in China and Correlation with High-Risk Factors and Multigene Testing Suggestions. Frontiers in Genetics. 12. 674094–674094. 13 indexed citations
15.
Li, J Y, Jin Li, Meizuo Zhong, Hui Zhou, & Baohua Yu. (2021). The Clinical Features and Survival Outcome of 107 Newly Diagnosed Advanced Stage Extranodal NK/T-Cell Lymphoma Cases: A Triple-Center Study. Cancer Management and Research. Volume 13. 1541–1549. 5 indexed citations
16.
Li, Yajun, J Y Li, Kailin Chen, et al.. (2020). HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases. Blood Research. 55(1). 49–56. 27 indexed citations
17.
Tian, Tian, J Y Li, Tian Xue, et al.. (2020). Microsatellite instability and its associations with the clinicopathologic characteristics of diffuse large B‐cell lymphoma. Cancer Medicine. 9(7). 2330–2342. 12 indexed citations
18.
Wang, Jingyuan, Huaiwen Zhang, Wei Xu, et al.. (2018). Dose fall-off during the treatment of thoracic spine metastasis with CyberKnife stereotactic body radiation therapy (SBRT). Bosnian Journal of Basic Medical Sciences. 20(1). 131–139. 2 indexed citations
19.
Li, Jin, Yajun Li, Meizuo Zhong, et al.. (2018). A Multicenter Retrospective Comparison of Sequential versus Sandwich Chemoradiotherapy for Stage IE-IIE Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. Journal of Cancer. 9(9). 1598–1606. 10 indexed citations
20.
Li, Yajun, Pingyong Yi, J Y Li, et al.. (2017). Prognostic role of ABO blood type in patients with extranodal natural killer/T cell lymphoma, nasal type: a triple-center study. Chinese Journal of Cancer. 36(1). 62–62. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026